Skip to main content
Caplight Logo









Medicsen

Medicsen

Private
MadridHealthcare & Life Scienceshttps://medicsen.com/en/

Last Round

Grant

Apr 29, 2024

Total Funding Raised

$525,000

Company Overview

Medicsen is a therapeutic devices company that has developed a needle-free smartpatch for the painless delivery of large-molecule drugs.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Clinical Trials, Patient Engagement

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Government Contracts

AI Layer

Application

Keywords

needle-free drug deliverysmartpatchultrasound drug deliverypainless drug deliveryinsulin deliverydiabetes managementsonophoresiswearable medical deviceartificial pancreasclosed-loop systemtransdermal drug deliverymacromolecular drug deliverymedtechpharmaceutical licensinghealth IoT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Medicsen Comparables

Compare Medicsen with similar companies based on industry and business-model similarity.

Medicsen comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Transdermal Specialties Global
89%
Portal Instruments
80%
Zenomics, Inc.
75%

Medicsen Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 29, 2024
GrantApr 8, 2020
SeedDec 1, 2017
GrantDec 1, 2016

Key People

Founding team and executive leadership

José Carlos Montesinos Pérez

CTO and Co-Founder

Founding Team

Eduardo W. Jørgensen de Vizcarrondo

CEO and Co-Founder

Founding Team

César de Mercado Santamarta

Chief Operating Officer

Executive Team

Medicsen Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 115% MoM.

  • Feb 18, 2026

    Grew 29% QoQ, from 21 to 27 employees.

Medicsen Filings

Explore SEC and related filing metadata, where available.

Medicsen filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Medicsen's valuation, stock price, and market status.

Is Medicsen a public or private company?

Medicsen is a private company.

What is the current stock price of Medicsen?

Medicsen is a private company with no public stock price. No recent secondary market data is available.

How much is Medicsen worth (valuation)?

Valuation information for Medicsen is not publicly available.

Can I buy Medicsen stock?

Medicsen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Medicsen's last funding round?

Funding round information for Medicsen is not publicly available.

Who are the main investors in Medicsen?

Investor information for Medicsen is not publicly disclosed.

Will Medicsen IPO soon?

No public IPO plans have been announced for Medicsen.

How can I track Medicsen secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Medicsen's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMadrid
Employee Range20
Year Founded2015
Last FundingApr 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?